Hoth Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Hoth Therapeutics has a total shareholder equity of $7.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $8.3M and $813.0K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$8.02m |
| Equity | US$7.49m |
| Total liabilities | US$813.03k |
| Total assets | US$8.31m |
Recent financial health updates
Here's Why We're Watching Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Situation
Nov 12
We're Not Very Worried About Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Rate
Jun 10Recent updates
Hoth Therapeutics partners with Altasciences to manufacture HT-TBI for brain injury
Sep 20Hoth Therapeutics granted grace days by Nasdaq to regain compliance with bid price rule
Jun 29Here's Why We're Watching Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Situation
Nov 12Hoth Therapeutics extends agreement for experimental antibiotic
Jun 18We're Not Very Worried About Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Rate
Jun 10Hoth Therapeutics expands research agreement with VCU for COVID-19 therapeutic
May 05Hoth Therapeutics shares rise 10% on developmental plans for HT-KIT in multiple orphan diseases and rare cancers
May 03Hoth provides pipeline and regulatory timeline update
Feb 02FDA grants Hoth Therapeutics Pre-IND meeting for HT-001, shares up 15%
Jan 13Hoth Therapeutics to initiate IND enabling studies of HT-001 in cancer
Jan 11Hoth Therapeutics inks deal for treatment of multi-drug resistant bacterial lung infections, shares up 15%
Jan 04Financial Position Analysis
Short Term Liabilities: HOTH's short term assets ($8.2M) exceed its short term liabilities ($810.3K).
Long Term Liabilities: HOTH's short term assets ($8.2M) exceed its long term liabilities ($2.7K).
Debt to Equity History and Analysis
Debt Level: HOTH is debt free.
Reducing Debt: HOTH has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: HOTH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: HOTH is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 15:28 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hoth Therapeutics, Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Jason Kolbert | D. Boral Capital LLC. |
| Raghuram Selvaraju | H.C. Wainwright & Co. |